3D Bioprinting for Next-Generation Personalized Medicine

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Tissue Engineering

Background:

• Personalized medicine aims to tailor treatments to individual patient needs.
• 3D bioprinting has emerged as a key technology for creating in vitro tissue and organ models.
• Current bioprinting limitations include precise cell deposition, differentiation, vascularization, and innervation.

Purpose of the Study:

• To review the principles and applications of 3D bioprinting in personalized medicine.
• To highlight predominant bioprinting techniques like extrusion printing and digital light processing (DLP).
• To discuss the potential of bioprinted constructs in regenerative medicine and drug discovery.

Main Methods:

• Review of existing literature on 3D bioprinting techniques.
• Focus on extrusion printing and digital light processing (DLP) methods.
• Discussion of applications in stem cell engraftment and high-throughput drug development models.

Main Results:

• 3D bioprinting offers novel opportunities for personalized medicine.
• Bioprinted constructs show promise for personalized implants and drug development.
• Significant technical challenges persist in achieving fully functional, anatomically realistic organs.

Conclusions:

• 3D bioprinting is a rapidly advancing technology with the potential to address critical challenges in personalized medicine.
• Despite current limitations, bioprinting is poised to empower individualized treatment strategies.
• Further research and development are needed to overcome technical hurdles in organ engineering.